Riluzole for motor neurone disease. More trials are needed.

Riluzole for motor neurone disease. More trials are needed.

Библиографические подробности
Главные авторы:	Sandercock, J, Burls, A, Hyde, C, Fry-Smith, A, Barton, P, Bryan, S, Stewart, A
Формат:	Journal article
Язык:	English
Опубликовано:	2001

Схожие документы

Riluzole for motor neurone disease [3] (multiple letters)
по: Sandercock, J, и др.
Опубликовано: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
по: Stewart, A, и др.
Опубликовано: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: A rapid and systematic review
по: Stewart, A, и др.
Опубликовано: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review
по: A. Stewart, и др.
Опубликовано: (2001-01-01)

Novel Tissue-Specific Multifunctionalized Nanotechnological Platform Encapsulating Riluzole Against Motor Neuron Diseases
по: Esteruelas G, и др.
Опубликовано: (2025-02-01)

Assessing the Effect of Riluzole on Motor Unit Discharge Properties
по: Ehsan Shandiz, и др.
Опубликовано: (2024-10-01)

Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons.
по: Diego Fernández-Fernández, и др.
Опубликовано: (2018-01-01)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
по: Selin Üstün Bezgin, и др.
Опубликовано: (2019-03-01)

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes
по: Luca Pagliaroli, и др.
Опубликовано: (2021-06-01)

NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
по: Barış Genç, и др.
Опубликовано: (2022-03-01)

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease
по: Emma Hockly, и др.
Опубликовано: (2006-01-01)

Riluzole Ameliorates Harmaline-Induced Tremor in Rat
по: Fatemeh Rahimi Shourmasti, и др.
Опубликовано: (2014-05-01)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
по: Introna A, и др.
Опубликовано: (2018-01-01)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
по: Brañas, и др.
Опубликовано: (2000-01-01)

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
по: Jaejeong Kim, и др.
Опубликовано: (2023-11-01)

Are systematic reviews more cost-effective than randomised trials?
по: Glasziou, P, и др.
Опубликовано: (2006)

Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons.
по: Rou-Gang Xie, и др.
Опубликовано: (2011-01-01)

Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
по: Aline Milane, и др.
Опубликовано: (2009-08-01)

Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins
по: Tatyana Volkova, и др.
Опубликовано: (2024-06-01)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
по: Dretzke, J, и др.
Опубликовано: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
по: Dretzke, J, и др.
Опубликовано: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
по: Dretzke, J, и др.
Опубликовано: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
по: J Dretzke, и др.
Опубликовано: (2004-06-01)

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon
по: Paróla A, и др.
Опубликовано: (2018-11-01)

Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review
по: Iván Nicolas Ayala, и др.
Опубликовано: (2022-08-01)

Riluzole use in presence of contraindications in adults affected by amyotrophic lateral sclerosis and its off-label use in other motor neuron diseases: Findings from an Italian multicentre study (the CAESAR project)
по: Giada Crescioli, и др.
Опубликовано: (2022-10-01)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
по: Dyer AM, и др.
Опубликовано: (2016-12-01)

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
по: Luqing Wei, и др.
Опубликовано: (2022-02-01)

Efficacy and safety of riluzole for treating motor function in rare dyskinesia syndromes: a systematic review with meta-analysis
по: Rui Wang, и др.
Опубликовано: (2024-09-01)

Treatments for fatigue in multiple sclerosis: A rapid and systematic review
по: Branas, P, и др.
Опубликовано: (2000)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
по: Brañas, P, и др.
Опубликовано: (2000)

The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
по: Albert C. Ludolph, и др.
Опубликовано: (2023-12-01)

Structural identification of riluzole-binding site on human TRPC5
по: Yaxiong Yang, и др.
Опубликовано: (2022-07-01)

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole
по: David Hollingworth, и др.
Опубликовано: (2024-09-01)

Congratulations to the NZMJ for the Unfortunate Experiment theme issue.
по: Sandercock, J, и др.
Опубликовано: (2010)

Decision-making under conditions of uncertainty-what can we learn from palivizumab?
по: Burls, A, и др.
Опубликовано: (2011)

How to make a compelling submission to NICE: tips for sponsoring organisations.
по: Burls, A, и др.
Опубликовано: (2003)

Decision-making under conditions of uncertainty-what can we learn from palivizumab?
по: Burls, A, и др.
Опубликовано: (2011)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
по: Burls, A, и др.
Опубликовано: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
по: Burls, A, и др.
Опубликовано: (2002)